<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PEN</journal-id>
<journal-id journal-id-type="hwp">sppen</journal-id>
<journal-id journal-id-type="nlm-ta">JPEN J Parenter Enteral Nutr</journal-id>
<journal-title>Journal of Parenteral and Enteral Nutrition</journal-title>
<issn pub-type="ppub">0148-6071</issn>
<issn pub-type="epub">1941-2444</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0148607112463076</article-id>
<article-id pub-id-type="publisher-id">10.1177_0148607112463076</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Communications</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cranberry Proanthocyanidins Improve the Gut Mucous Layer Morphology and Function in Mice Receiving Elemental Enteral Nutrition</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Pierre</surname><given-names>Joseph F.</given-names></name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff1-0148607112463076">1</xref>
<xref ref-type="aff" rid="aff2-0148607112463076">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Heneghan</surname><given-names>Aaron F.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112463076">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Feliciano</surname><given-names>Rodrigo P.</given-names></name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff2-0148607112463076">2</xref>
<xref ref-type="aff" rid="aff3-0148607112463076">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Shanmuganayagam</surname><given-names>Dhanansayan</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-0148607112463076">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Roenneburg</surname><given-names>Drew A.</given-names></name>
<degrees>MPH</degrees>
<xref ref-type="aff" rid="aff1-0148607112463076">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Krueger</surname><given-names>Christian G.</given-names></name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff2-0148607112463076">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Reed</surname><given-names>Jess D.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-0148607112463076">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kudsk</surname><given-names>Kenneth A.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0148607112463076">1</xref>
<xref ref-type="aff" rid="aff4-0148607112463076">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-0148607112463076"><label>1</label>Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin</aff>
<aff id="aff2-0148607112463076"><label>2</label>Department of Animal Sciences, University of Wisconsin, Madison, Wisconsin</aff>
<aff id="aff3-0148607112463076"><label>3</label>Department of Food Science, University of Wisconsin, Madison, Wisconsin</aff>
<aff id="aff4-0148607112463076"><label>4</label>Veterans Administration Surgical Services, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin</aff>
<author-notes>
<corresp id="corresp1-0148607112463076">Kenneth A. Kudsk, MD, G5/341 Clinical Sciences Center, 600 Highland Ave, Madison, WI 53792-7375, USA. Email: <email>kudsk@surgery.wisc.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>37</volume>
<issue>3</issue>
<fpage>401</fpage>
<lpage>409</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>5</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>8</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p><italic>Background:</italic> Lamina propria Th2 cytokines, interleukin (IL)-4 and IL-13, stimulate goblet cell (GC) proliferation and MUC2 production, which protect the intestinal mucosa. Elemental enteral nutrition (EEN) reduces tissue IL-4 and impairs barrier function. Proanthocyanidins (PACs) stimulate oral mucin levels. We hypothesized that adding PAC to EEN would maintain Th2–without stimulating Th1–cytokines and preserve luminal MUC2 vs EEN alone. <italic>Materials and Methods:</italic> Seventy mice were randomized to 5 diet groups–standard chow, intragastric EEN, or EEN with lowPAC, midPAC (50 mg), or highPAC (100 mg PAC/kg BW)–for 5 days, starting 2 days after gastric cannulation. Ileal tissue was analyzed for histomorphology and the cytokines IL-4, IL-13, IL-1β, IL-6, and TNF-α by enzyme-linked immunosorbent assay. MUC2 was measured in intestinal washes. <italic>Results:</italic> EEN lowered IL-13 (P &lt; .05) compared with standard chow, whereas IL-4 was not significant (P &lt; .07). LowPAC and midPAC increased IL-13 (P &lt; .05), whereas highPAC increased both IL-4 and IL-13 (P &lt; .05) compared with EEN. All EEN diets reduced (P &lt; .05) crypt depth compared with the chow group. Compared with standard chow, GC numbers and luminal MUC2 were reduced with EEN (P &lt; .05). These effects were attenuated (P &lt; .05) with midPAC and highPAC. No changes were observed in tissue Th1 cytokines. <italic>Conclusions:</italic> Adding PACs to EEN reverses impaired intestinal barrier function following EEN by improving the gut mucous layer and function through increased GC size and number as well as levels of MUC2 and ileal IL-4 and IL-13.</p>
</abstract>
<kwd-group>
<kwd>enteral nutrition</kwd>
<kwd>proanthocyanidins</kwd>
<kwd>goblet cells</kwd>
<kwd>mucin</kwd>
<kwd>cytokines</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0148607112463076">
<title>Clinical Relevancy Statement</title>
<p>Multiple components of the intestinal mucosal barrier, including secreted mucus and antimicrobial compounds, maintain the host-bacterial relationship within the gut lumen. Elemental enteral nutrition adversely affects mucus production and secretion, impairing the most basic level of gut immunity—barrier function. The addition of a complex, unabsorbed phytochemical, proanthocyanidins, to elemental nutrition improves this aspect of mucosal defense.</p>
</sec>
<sec id="section2-0148607112463076" sec-type="intro">
<title>Introduction</title>
<p>Elemental enteral nutrition (EEN) is a therapeutic option for inflammatory bowel disorders such as Crohn’s disease.<sup><xref ref-type="bibr" rid="bibr1-0148607112463076">1</xref></sup> Unfortunately, EEN induces well-defined dysfunction of the mucosal immune system, specifically within the gut-associated lymphoid tissue (GALT), and suppresses mucosal barrier function when compared with normal nutrition.<sup><xref ref-type="bibr" rid="bibr2-0148607112463076">2</xref><xref ref-type="bibr" rid="bibr3-0148607112463076"/><xref ref-type="bibr" rid="bibr4-0148607112463076"/>-<xref ref-type="bibr" rid="bibr5-0148607112463076">5</xref></sup> The integrity of the mucosal barrier is critical for maintaining the physical and chemical barrier against food and environmental antigens, including microbes.<sup><xref ref-type="bibr" rid="bibr6-0148607112463076">6</xref></sup> The mucosal barrier is partly dependent on the physical and compositional characteristics of the mucous layer.<sup><xref ref-type="bibr" rid="bibr7-0148607112463076">7</xref></sup> Dietary compounds that affect this layer may have implications in health through modulation of the intestinal barrier.<sup><xref ref-type="bibr" rid="bibr8-0148607112463076">8</xref></sup></p>
<p>Proanthocyanidins (PACs) are a class of polyphenolic compounds widely distributed in plant-derived foods and beverages<sup><xref ref-type="bibr" rid="bibr9-0148607112463076">9</xref><xref ref-type="bibr" rid="bibr10-0148607112463076"/>-<xref ref-type="bibr" rid="bibr11-0148607112463076">11</xref></sup> that are associated with the prevention of chronic diseases in epidemiological studies.<sup><xref ref-type="bibr" rid="bibr12-0148607112463076">12</xref><xref ref-type="bibr" rid="bibr13-0148607112463076"/>-<xref ref-type="bibr" rid="bibr14-0148607112463076">14</xref></sup> However, PACs are minimally absorbed due to nonhydrolyzable bonds between monomeric subunits and a propensity to bind proteins through hydrogen bonding.<sup><xref ref-type="bibr" rid="bibr15-0148607112463076">15</xref></sup> PACs complex salivary glycoproteins, a process that causes astringency in the oral cavity when many fruits and beverages are ingested.<sup><xref ref-type="bibr" rid="bibr16-0148607112463076">16</xref></sup> Complexation induces salivary excretion, hypertrophy of the parotid gland, and a shift in salivary composition to proline-rich glycoproteins in rodents.<sup><xref ref-type="bibr" rid="bibr16-0148607112463076">16</xref>,<xref ref-type="bibr" rid="bibr17-0148607112463076">17</xref></sup> Because of poor absorption, &gt;95% of PACs remain in the intestinal lumen during transit,<sup><xref ref-type="bibr" rid="bibr18-0148607112463076">18</xref>,<xref ref-type="bibr" rid="bibr19-0148607112463076">19</xref></sup> suggesting that beneficial dietary effects of PACs may occur through interactions at the mucosal surface of the gastrointestinal tract,<sup><xref ref-type="bibr" rid="bibr8-0148607112463076">8</xref></sup> for example, by influencing secretion of mucins, a class of glycoproteins, in the small intestine.<sup><xref ref-type="bibr" rid="bibr14-0148607112463076">14</xref>,<xref ref-type="bibr" rid="bibr20-0148607112463076">20</xref></sup></p>
<p>Mucins are secreted by goblet cells (GCs) and play a critical role in maintaining mucosal integrity.<sup><xref ref-type="bibr" rid="bibr7-0148607112463076">7</xref></sup> GCs, specialized intestinal epithelial cells, migrate up the villi after differentiating from crypt stem cells, turning over with the epithelial layer every 3–5 days. Mucin 2 (MUC2) is the most abundant mucin secreted by intestinal GC. The importance of MUC2 is underscored in MUC2<sup>–/–</sup> mice, in which the deficiency leads to the development of lethal colitis.<sup><xref ref-type="bibr" rid="bibr21-0148607112463076">21</xref></sup> MUC2 secretion is induced by cholinergic stimulation,<sup><xref ref-type="bibr" rid="bibr22-0148607112463076">22</xref></sup> while its production is regulated by the T-helper 2 (Th-2) cytokines interleukin (IL)–4 and IL-13, derived from lamina propria or intraepithelial lymphocytes.<sup><xref ref-type="bibr" rid="bibr23-0148607112463076">23</xref>-<xref ref-type="bibr" rid="bibr25-0148607112463076">25</xref></sup></p>
<p>In this study, we hypothesized that the addition of physiologically relevant doses<sup><xref ref-type="bibr" rid="bibr26-0148607112463076">26</xref>,<xref ref-type="bibr" rid="bibr27-0148607112463076">27</xref></sup> of cranberry PAC (8–100 mg gallic acid equivalents [GAE]/kg body weight) to EEN would attenuate the negative effects of EEN on intestinal barrier function as determined by changes in the Th-2 cytokines IL-4 and IL-13, GC number and size, and luminal MUC2. In addition, we examined potential changes in proinflammatory Th1 cytokines (IL-1β, IL-6, and tumor necrosis factor [TNF]–α)<sup><xref ref-type="bibr" rid="bibr28-0148607112463076">28</xref>,<xref ref-type="bibr" rid="bibr29-0148607112463076">29</xref></sup> and histomorphometric parameters (eg, villi length and crypt depth).<sup><xref ref-type="bibr" rid="bibr30-0148607112463076">30</xref></sup></p>
</sec>
<sec id="section3-0148607112463076" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section4-0148607112463076">
<title>PAC Preparation and Characterization</title>
<p>The methodology for PAC preparation and characterization was previously published.<sup><xref ref-type="bibr" rid="bibr31-0148607112463076">31</xref></sup> Briefly, non-depectinized cranberry presscake was ground with liquid nitrogen and extracted with 70% acetone (Fisher Scientific, Fair Lawn, NJ). Samples were sonicated and centrifuged for 10 minutes. The extraction was repeated twice. Acetone was removed by evaporation and the aqueous suspension was solubilized in ethanol (Decon Labs, Inc, King of Prussia, PA), followed by centrifugation to eliminate ethanol insoluble material. Cranberry presscake crude extract was loaded on a Sephadex LH-20 (GE Healthcare, Uppsala, Sweden), column and PACs were isolated by sequential elution with ethanol, ethanol/methanol (1:1), and 80% acetone. Acetone in the last fraction that contained PAC was removed by evaporation under vacuum and resolubilized in methanol (Fisher Scientific). The total phenolic content of the PAC fraction was determined by the modified Folin-Ciocalteu method and reported as GAE.</p>
<p>An aliquot of the cranberry presscake PAC fraction was diluted 10-fold and a sample was injected onto a Waters Spherisorb (Aldrich, Milwaukee, WI) 10-µm ODS2 RP-18 column. The solvents for elution were trifluoroacetic acid/water (0.1%) and methanol. The high-performance liquid chromatography (HPLC) system consisted of a Waters automated gradient controller, 2 Waters 501 HPLC pumps, and a Rheodyne 7125 manual injector. The elution was monitored by a Waters 996 diode array detector using Waters Millennium software for collecting and analyzing 3-dimensional chromatograms.</p>
<p>An aliquot of the cranberry presscake PAC fraction was mixed with 2,5-dihydroxybenzoic acid and the mixture was applied onto a matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS) stainless steel target and dried at room temperature. Mass spectra were collected on a Bruker Reflex II MALDI-TOF-MS (Billerica, MA) equipped with delayed extraction and an N<sub>2</sub> laser (337 nm) to characterize the range in degree of polymerization (DP) and nature of interflavan bonds in the cranberry PAC. All preparations were analyzed in the positive ion linear and reflectron mode to detect [M + Na]<sup>+</sup> and [M + K]<sup>+</sup> molecular ions. MALDI-TOF MS is ideally suited for characterizing PAC because, unlike electrospray ionization in which multiple charge molecular ions create very complex spectral peaks that are often difficult to interpret, this mass spectral technique produces only a singly charged molecular ion for each parent molecule.<sup><xref ref-type="bibr" rid="bibr11-0148607112463076">11</xref></sup></p>
</sec>
<sec id="section5-0148607112463076">
<title>Animals</title>
<p>All animal experiment protocols were approved by Animal Care and Use Committee of the University of Wisconsin–Madison and the Middleton Veterans Administration Hospital, Madison. Male Institute of Cancer Research (ICR) outbred mice were purchased through Harlan (Indianapolis, IN) and housed in an American Association for Accreditation of Laboratory Animal Care–accredited conventional facility on the Veterans Administration (VA) Williamson Hospital Campus. The mice were acclimatized for 1 week in a temperature- and humidity-controlled environment with a 12-hour/12-hour light/dark cycle. The mice were housed 5 per micro isolater-top cages and fed ad libitum chow (Rodent Diet 5001, LabDiet; PMI Nutrition International, St Louis, MO) and water for 1 week prior to initiation of the study protocol. A description and detailed chemical composition of Rodent Diet 5001 is available at <ext-link ext-link-type="uri" xlink:href="http://labdiet.com/pdf/5001.pdf">http://labdiet.com/pdf/5001.pdf</ext-link>. Once entering the study protocol, the mice were housed individually in metal wire–bottomed cages to prevent coprophagia and ingestion of bedding.</p>
</sec>
<sec id="section6-0148607112463076">
<title>Experimental Design</title>
<p>Seventy male ICR mice (6–8 weeks old) were randomized by weight (n = 14/diet group) to receive standard chow, intragastric EEN, or intragastric EEN + PAC (8 mg [EEN + lowPAC], 50 mg [EEN + midPAC], or 100 mg [EEN + highPAC] GAE of PAC/kg body weight). Animals were anesthetized with intraperitoneal administration of ketamine (100 mg/kg) and acepromazine (10 mg/kg) and gastrostomy was performed. Catheters were tunneled subcutaneously from the gastrostomy site, over the back, finally exiting mid-tail. The mice were partially restrained by the tail for the remainder of the study to protect the catheter during infusions. This partial-restraint technique does not induce significant stress in the mice.<sup><xref ref-type="bibr" rid="bibr32-0148607112463076">32</xref></sup> The catheterized mice were connected to infusion pumps and allowed to recover for 48 hours while receiving 4 mL/d of saline (0.9%) via the catheter. The mice also received ad libitum chow (Rodent Diet 5001, LabDiet) and water.</p>
<p>Following the recovery period, animals received their assigned dietary treatments. The mice fed standard chow were given ad libitum chow diet and water and continued to receive 0.9% saline at 4 mL/d via the intragastric catheter. Mice fed EEN and EEN + PAC received solution at 4 mL/d (day 1), 7 mL/d (day 2), and 10 mL/d (days 3–5) as well as ad libitum water throughout the study. The EEN solution includes 6.0% amino acids, 35.6% dextrose, electrolytes, and multivitamins, with a nonprotein calorie to nitrogen ratio of 126.1 (527.0 kJ/g nitrogen) (<xref ref-type="table" rid="table1-0148607112463076">Table 1</xref>). This value meets the calculated nutrient requirements of mice weighing 30–35 g.<sup><xref ref-type="bibr" rid="bibr33-0148607112463076">33</xref></sup></p>
<table-wrap id="table1-0148607112463076" position="float">
<label>Table 1.</label>
<caption><p>Formulation of Elemental Enteral Nutrition Solution.</p></caption>
<graphic alternate-form-of="table1-0148607112463076" xlink:href="10.1177_0148607112463076-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Component</th>
<th align="center">Amount (per 1 L)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dextrose, g</td>
<td>356.0</td>
</tr>
<tr>
<td>Amino acids (Clinisol), g</td>
<td>60.0</td>
</tr>
<tr>
<td>Sodium chloride, mEq</td>
<td>32.0</td>
</tr>
<tr>
<td>Sodium phosphate, mmol</td>
<td>36</td>
</tr>
<tr>
<td>Potassium chloride, mEq</td>
<td>16</td>
</tr>
<tr>
<td>Calcium gluconate, mEq</td>
<td>37.5</td>
</tr>
<tr>
<td>Potassium acetate, mEq</td>
<td>44.0</td>
</tr>
<tr>
<td>Magnesium sulfate, mEq</td>
<td>8.0</td>
</tr>
<tr>
<td>Manganese, mg</td>
<td>0.8</td>
</tr>
<tr>
<td>Copper, µg</td>
<td>0.5</td>
</tr>
<tr>
<td>Zinc, mg</td>
<td>2.0</td>
</tr>
<tr>
<td>Vitamin C, mg</td>
<td>200</td>
</tr>
<tr>
<td>Vitamin A, IU</td>
<td>3300</td>
</tr>
<tr>
<td>Vitamin D<sub>3</sub>, IU</td>
<td>200</td>
</tr>
<tr>
<td>Thiamine, mg</td>
<td>6</td>
</tr>
<tr>
<td>Riboflavin, mg</td>
<td>3.6</td>
</tr>
<tr>
<td>Pyridoxine HCl, mg</td>
<td>6</td>
</tr>
<tr>
<td>Niacinamide, mg</td>
<td>40</td>
</tr>
<tr>
<td>Folic acid, mcg</td>
<td>600</td>
</tr>
<tr>
<td>Biotin, mcg</td>
<td>60</td>
</tr>
<tr>
<td>Cyanocobalamin, mcg</td>
<td>5</td>
</tr>
<tr>
<td>Vitamin E (<italic>dl</italic>-α-tocopheryl acetate), IU</td>
<td>10</td>
</tr>
<tr>
<td>Vitamin K<sub>1</sub>, mcg</td>
<td>150</td>
</tr>
<tr>
<td>Dexpanthenol, mg</td>
<td>15</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0148607112463076">
<p>IU, international units.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>After 5 days of feeding (7 days postcatheterization), mice were weighed, anesthetized as before, and exsanguinated via left axillary artery transection. The small intestine from each mouse was removed and the lumen rinsed with 20 mL Hank’s balanced salt solution (HBSS; Bio Whittaker, Walkersville, MD). The luminal rinse was centrifuged at 2000 <italic>g</italic> for 10 minutes, and supernatant was aliquoted and frozen at −80°C for MUC2 analysis. Ileal tissue samples were obtained from a 3-cm segment of ileum that excluded Peyer’s patches. Samples for cytokine determination were flash-frozen in liquid N<sub>2</sub> with 1% protease inhibitor cocktail (p8340; Sigma-Aldrich) and stored at −80°C until subsequent analysis, whereas samples for GC analysis were fixed in 4% paraformaldehyde overnight, transferred to 70% ethanol, and stored at 4°C until subsequent histology.</p>
</sec>
<sec id="section7-0148607112463076">
<title>Analysis of Ileal Cytokines</title>
<p>The flash-frozen small intestine segment from each animal was homogenized in RIPA lysis buffer (Upstate, Lake Placid, NY) containing 1% protease inhibitor cocktail (Sigma-Aldrich). The homogenate was kept on ice for 30 minutes prior to centrifugation at 16,000 <italic>g</italic> for 10 minutes at 4°C. The supernatant was then stored at −20°C until analysis. Prior to storage, the protein concentration of the supernatant was determined by the Bradford method using bovine serum albumin (BSA) as a standard.</p>
<p>Concentrations of IL-4, IL-13, IL-1β, IL-6, and TNF-α were determined in the supernatant using solid-phase sandwich enzyme-linked immunosorbent assay (ELISA) kits (BD Biosciences, San Diego, CA), according to the manufacturer’s instructions and identical to our previous work.<sup><xref ref-type="bibr" rid="bibr5-0148607112463076">5</xref>,<xref ref-type="bibr" rid="bibr34-0148607112463076">34</xref></sup> The absorbance at 450 nm was determined using a V<sub>max</sub> Kinetic Microplate Reader (Molecular Devices, Sunnyvale, CA). The respective cytokine concentrations in the samples were determined by using a 4-parameter logistic fit standard curve (SOFTmax PRO software; Molecular Devices) and normalized to total tissue protein content.</p>
</sec>
<sec id="section8-0148607112463076">
<title>Analysis of Luminal MUC2</title>
<p>Our method of MUC2 analysis was similar to previous work.<sup><xref ref-type="bibr" rid="bibr35-0148607112463076">35</xref><xref ref-type="bibr" rid="bibr36-0148607112463076"/><xref ref-type="bibr" rid="bibr37-0148607112463076"/>-<xref ref-type="bibr" rid="bibr38-0148607112463076">38</xref></sup> Proteins in the intestinal wash fluid (4 µL) from each animal were separated by 10% agarose gel by electrophoresis at 150V for 80 minutes at room temperature. The resolved proteins were transferred to a polyvinylidene fluoride membrane using Tris-glycine buffer containing 20% methanol at 80V for 60 minutes at 4°C. The membrane was blocked with 5% nonfat dry milk prepared in Tris-buffered saline containing Tween (0.05%) for 1 hour at room temperature with constant agitation. Then, the membrane was incubated with mouse anti-human MUC2 (ab-11197; Abcam, Cambridge, MA) primary antibody (diluted 1:2500) overnight at 4°C with constant agitation. The membrane was washed and incubated with stabilized goat anti-mouse IgG–horseradish peroxidase (HRP) conjugate (sc-2005; Santa Cruz Biotechnology, Santa Cruz, CA) secondary antibody (diluted 1:20,000) for 1 hour at room temperature with constant agitation. After washing, the membrane was incubated with HRP substrate (Super Signal West Femto substrate; Pierce, Rockford, IL) for 5 minutes, and the protein of interest (MUC2) was detected using photographic film. The relative intensities of both the monomeric and dimeric forms of MUC2 were determined together for each sample using National Institutes of Health (NIH) ImageJ software (version 1.43, <ext-link ext-link-type="uri" xlink:href="http://rsbweb.nih.gov/ij/">http://rsbweb.nih.gov/ij/</ext-link>); internal controls were used to normalize the densitometry across multiple films.</p>
</sec>
<sec id="section9-0148607112463076">
<title>Histomorphometric Analysis</title>
<p>The fixed ileal tissue sections were processed (Tissue-Tek V.I.P.; Sakura Finetek, Torrance, CA) and embedded in paraffin. The embedded tissue was cut (5 µm thick), deparaffinized, rehydrated through graded ethanol washes (100% ethanol × 2, 95% ethanol × 2, 70% ethanol × 1, 2 minutes each), and placed into distilled H<sub>2</sub>O. Samples were stained with periodic acid-Schiff (PAS) and counterstained with hematoxylin. GC number was determined by determining the average number of GCs present in 15 individual villi per animal. GC size (µm<sup>2</sup>) was obtained by imaging tissue sections and analyzing individual GC area with NIH ImageJ software (version 1.43). Villi length and crypt depth measurements were determined in 15 villi and crypts. The histomorphometric measurements were performed by 2 independent, blinded researchers.</p>
</sec>
<sec id="section10-0148607112463076">
<title>Statistical Analysis</title>
<p>A fixed-effects analysis of variance (ANOVA) model was fit for each measured parameter using the PROC MIXED function of the statistical software (SAS software, version 8; SAS Institute, Inc, Cary, NC) to test for significant effects of diet. The correlations between observations between diet groups were modeled using a diagonal covariance structure. For each measured parameter, the model was fit using the untransformed data, and the residuals were evaluated to ensure that standard ANOVA assumptions of constant variance and normality were reasonably met. Transformations of the data were performed if required to improve adherence to these assumptions. Type III tests were then performed to evaluate the significance of the effects of interest for each measured parameter, and least squares means were calculated for the diet groups. Primary effects of interest were differences between the (1) standard chow and EEN groups, (2) EEN and EEN + PAC groups (at each dose), and (3) standard chow and EEN + PAC groups (at each dose). The standard chow group was included in the analysis as a positive control as done in all of our previous work. The data are reported as least squares mean ± standard error of mean (SEM). Statistical significance was accepted at <italic>P</italic> &lt; .05.</p>
</sec>
</sec>
<sec id="section11-0148607112463076" sec-type="results">
<title>Results</title>
<sec id="section12-0148607112463076">
<title>PAC Characterization by HPLC and MALDI-TOF MS</title>
<p>The cranberry presscake PAC eluted as 2 unresolved peaks that had absorbance at 280 nm and minor absorbance at 520 nm due to the presence of covalently linked anthocyanin- proanthocyanidin pigments. No peaks were observed with an absorbance max typical of the other classes of cranberry polyphenolic compounds (anthocyanins, hydroxycinnamic acids, and flavonols). The poorly resolved chromatogram at 280 nm is due to structural heterogeneity of cranberry presscake PAC.<sup><xref ref-type="bibr" rid="bibr11-0148607112463076">11</xref></sup></p>
<p>Reflectron mode MALDI-TOF MS showed masses that correspond to PAC with at least 1A-type interflavan bond in trimers to undecamers. MALDI-TOF MS linear mode spectra had m/z peaks that correspond to cranberry presscake PAC with a range of 3–23 degrees of polymerization. The spectra also contained m/z peaks that correspond to covalently linked anthocyanin-proanthocyanidin molecules, ranging from monomers to heptamers (data not shown).</p>
</sec>
<sec id="section13-0148607112463076">
<title>Body Weight Changes</title>
<p>Preexperiment body weights did not significantly differ between treatment groups. Postexperiment body weights were significantly (<italic>P</italic> &lt; .05) lower in all EEN-fed groups compared with standard chow (<xref ref-type="table" rid="table2-0148607112463076">Table 2</xref>). The decrease in body weight observed in EEN groups is partly due to absence of bowel fecal content, which we have measured previously at 1–1.5 grams. Postexperiment body weight between EEN-fed groups did not differ.</p>
<table-wrap id="table2-0148607112463076" position="float">
<label>Table 2.</label>
<caption><p>Experimental Body Weights.</p></caption>
<graphic alternate-form-of="table2-0148607112463076" xlink:href="10.1177_0148607112463076-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Weight by Timepoint</th>
<th align="center">Chow</th>
<th align="center">EEN</th>
<th align="center">EEN + lowPAC</th>
<th align="center">EEN + midPAC</th>
<th align="center">EEN + highPAC</th>
</tr>
</thead>
<tbody>
<tr>
<td>Preexperiment weight, g</td>
<td>32.88 ± 0.53</td>
<td>34.23 ± 0.60</td>
<td>32.44 ± 0.85</td>
<td>34.14 ± 0.73</td>
<td>33.40 ± 0.60</td>
</tr>
<tr>
<td>Postexperiment weight, g</td>
<td>30.44 ± 0.87</td>
<td>27.29 ± 0.67<sup><xref ref-type="table-fn" rid="table-fn3-0148607112463076">a</xref></sup></td>
<td>26.71 ± 0.62<sup><xref ref-type="table-fn" rid="table-fn3-0148607112463076">a</xref></sup></td>
<td>28.02 ± 0.76<sup><xref ref-type="table-fn" rid="table-fn3-0148607112463076">a</xref></sup></td>
<td>27.64 ± 0.52<sup><xref ref-type="table-fn" rid="table-fn3-0148607112463076">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0148607112463076">
<p>Values are mean ± SEM; n = 12–14. BW, body weight; EEN, elemental enteral nutrition; EEN + lowPAC, EEN with 8 mg/kg BW PAC; EEN + midPAC, EEN with 50 mg/kg BW PAC; EEN + highPAC, EEN with 100 mg/kg BW PAC; PAC, proanthocyanidin.</p>
</fn>
<fn id="table-fn3-0148607112463076">
<label>a</label>
<p><italic>P</italic> &lt; .05 vs chow.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section14-0148607112463076">
<title>Analysis of Ileal Cytokines</title>
<p>IL-4 level in the ileal tissue of the EEN group was lower than in the standard chow group, almost reaching statistical significance (<italic>P</italic> = .051) (<xref ref-type="table" rid="table3-0148607112463076">Table 3</xref>). IL-4 levels in the EEN + highPAC group were significantly higher than in the EEN group (<italic>P</italic> &lt; .005), whereas levels in the EEN + lowPAC andEEN + midPAC groups did not significantly differ from the EEN group. In addition, tissue IL-4 was significantly greater in EEN + highPAC than in EEN + lowPAC (<italic>P</italic> &lt; .005).</p>
<table-wrap id="table3-0148607112463076" position="float">
<label>Table 3.</label>
<caption><p>Effects of Feeding Chow, EEN, EEN + lowPAC, EEN + midPAC, and EEN + highPAC Diets on Intestinal Tissue Cytokines, IL-4, IL-13, IL-1β, IL-6, and TNF-α.</p></caption>
<graphic alternate-form-of="table3-0148607112463076" xlink:href="10.1177_0148607112463076-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Tissue Cytokine</th>
<th align="center">Chow</th>
<th align="center">EEN</th>
<th align="center">EEN + lowPAC</th>
<th align="center">EEN + midPAC</th>
<th align="center">EEN + highPAC</th>
</tr>
</thead>
<tbody>
<tr>
<td>IL-4, pg/mg protein</td>
<td>6.01 ± 0.56</td>
<td>4.48 ± 0.52</td>
<td>4.98 ± 0.52</td>
<td>5.81 ± 0.52</td>
<td>6.99 ± 0.52<sup><xref ref-type="table-fn" rid="table-fn5-0148607112463076">a</xref></sup></td>
</tr>
<tr>
<td>IL-13, pg/mg protein</td>
<td>11.37 ± 1.63</td>
<td>7.54 ± 1.42<sup><xref ref-type="table-fn" rid="table-fn6-0148607112463076">b</xref></sup></td>
<td>10.94 ± 1.42<sup><xref ref-type="table-fn" rid="table-fn5-0148607112463076">a</xref></sup></td>
<td>11.83 ± 1.42<sup><xref ref-type="table-fn" rid="table-fn5-0148607112463076">a</xref></sup></td>
<td>13.94 ± 1.79<sup><xref ref-type="table-fn" rid="table-fn5-0148607112463076">a</xref></sup></td>
</tr>
<tr>
<td>IL-6, pg/mg protein</td>
<td>7.55 ± 0.78 (NS)</td>
<td>6.94 ± 0.75</td>
<td>7.19 ± 0.75</td>
<td>7.40 ± 0.75</td>
<td>7.04 ± 0.73</td>
</tr>
<tr>
<td>TNF-α, pg/mg protein</td>
<td>14.74 ± 2.67 (NS)</td>
<td>18.29 ± 2.38</td>
<td>17.63 ± 2.46</td>
<td>17.69 ± 2.38</td>
<td>12.83 ± 2.38</td>
</tr>
<tr>
<td>IL-1β, pg/mg protein</td>
<td>167.7 ± 18.06 (NS)</td>
<td>153.7 ± 16.8</td>
<td>129.3 ± 18.8</td>
<td>166.8 ± 16.8</td>
<td>114.7 ± 16.8</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0148607112463076">
<p>Values are mean ± SEM; n = 6–14. BW, body weight; EEN, elemental enteral nutrition; EEN + lowPAC, EEN with 8 mg/kg BW PAC; EEN + midPAC, EEN with 50 mg/kg BW PAC; EEN + highPAC, EEN with 100 mg/kg BW PAC; IL, interleukin; NS, nonsignificant effect across groups; PAC, proanthocyanidin; TNF-α, tumor necrosis factor–α.</p></fn>
<fn id="table-fn5-0148607112463076">
<label>a</label>
<p><italic>P</italic> &lt; .05 vs EEN.</p>
</fn>
<fn id="table-fn6-0148607112463076">
<label>b</label>
<p><italic>P</italic> &lt; .05 vs chow.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>EEN significantly reduced IL-13 in the ileal tissue compared with standard chow (<italic>P</italic> &lt; .05). IL-13 levels in the EEN + lowPAC (<italic>P</italic> &lt; .05), EEN + midPAC (<italic>P</italic> &lt; .05), and EEN + highPAC (<italic>P</italic> &lt; .005) groups were significantly higher than in the EEN group alone.</p>
<p>Compared with standard chow, EEN did not significantly affect the Th1 cytokines, IL-1β, IL-6, or TNF-α; the addition of PACs at any dose had no effect on these cytokines.</p>
</sec>
<sec id="section15-0148607112463076">
<title>Analysis of GC Number and Size</title>
<p>Although the length of villi was decreased in all EEN-fed groups compared with standard chow, these changes were not significant. However, there was a significant reduction in crypt depth with all EEN diets (<italic>P</italic> &lt; .05) compared with standard chow. The addition of PAC to EEN had no significant effect on villi length or crypt depth compared with the EEN alone (<xref ref-type="table" rid="table4-0148607112463076">Table 4</xref>).</p>
<table-wrap id="table4-0148607112463076" position="float">
<label>Table 4.</label>
<caption><p>Effects of Feeding Chow, EEN, EEN + lowPAC, EEN + midPAC, and EEN + highPAC on Intestinal Histomorphometry.</p></caption>
<graphic alternate-form-of="table4-0148607112463076" xlink:href="10.1177_0148607112463076-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Intestinal Parameter</th>
<th align="center">Chow</th>
<th align="center">EEN</th>
<th align="center">EEN + lowPAC</th>
<th align="center">EEN + midPAC</th>
<th align="center">EEN + highPAC</th>
</tr>
</thead>
<tbody>
<tr>
<td>Villi length, µm</td>
<td>171.5 ± 5.49 (NS)</td>
<td>155.5 ± 5.14</td>
<td>152.5 ± 5.50</td>
<td>157.0 ± 5.50</td>
<td>155.4 ± 5.50</td>
</tr>
<tr>
<td>Crypt depth, µm</td>
<td>79.99 ± 2.73</td>
<td>64.83 ± 2.55<sup><xref ref-type="table-fn" rid="table-fn8-0148607112463076">a</xref></sup></td>
<td>66.14 ± 2.73<sup><xref ref-type="table-fn" rid="table-fn8-0148607112463076">a</xref></sup></td>
<td>64.17 ± 2.73<sup><xref ref-type="table-fn" rid="table-fn8-0148607112463076">a</xref></sup></td>
<td>66.17 ± 2.73<sup><xref ref-type="table-fn" rid="table-fn8-0148607112463076">a</xref></sup></td>
</tr>
<tr>
<td>GC/villi, N</td>
<td>9.72 ± 0.44</td>
<td>7.98 ± 0.36</td>
<td>9.15 ± 0.44<sup><xref ref-type="table-fn" rid="table-fn9-0148607112463076">b</xref></sup></td>
<td>9.66 ± 0.48<sup><xref ref-type="table-fn" rid="table-fn9-0148607112463076">b</xref></sup></td>
<td>10.37 ± 0.39<sup><xref ref-type="table-fn" rid="table-fn9-0148607112463076">b</xref>,<xref ref-type="table-fn" rid="table-fn9-0148607112463076">b</xref></sup></td>
</tr>
<tr>
<td>GC/villi length, N/µm</td>
<td>0.0598 ± 0.0036</td>
<td>0.0522 ± 0.0033</td>
<td>0.0598 ± 0.0036</td>
<td>0.0619 ± 0.0036<sup><xref ref-type="table-fn" rid="table-fn9-0148607112463076">b</xref></sup></td>
<td>0.0657 ± 0.0036<sup><xref ref-type="table-fn" rid="table-fn9-0148607112463076">b</xref></sup></td>
</tr>
<tr>
<td>GC area, µm<sup>2</sup></td>
<td>54.49</td>
<td>48.56</td>
<td>62.57<sup><xref ref-type="table-fn" rid="table-fn9-0148607112463076">b</xref></sup></td>
<td>64.50<sup><xref ref-type="table-fn" rid="table-fn9-0148607112463076">b</xref></sup></td>
<td>61.50<sup><xref ref-type="table-fn" rid="table-fn9-0148607112463076">b</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-0148607112463076">
<p>Values are mean ± SEM; n = 8–14. BW, body weight; EEN, elemental enteral nutrition; EEN + lowPAC, EEN with 8 mg/kg BW PAC; EEN + midPAC, EEN with 50 mg/kg BW PAC; EEN + highPAC, EEN with 100 mg/kg BW PAC; GC, goblet cell; NS, nonsignificant effect across groups; PAC, proanthocyanidin.</p>
</fn>
<fn id="table-fn8-0148607112463076">
<label>a</label>
<p><italic>P</italic> &lt; .05 vs chow.</p>
</fn>
<fn id="table-fn9-0148607112463076">
<label>b</label>
<p><italic>P</italic> &lt; .05 vs EEN.</p>
</fn>
<fn id="table-fn10-0148607112463076">
<label>c</label>
<p><italic>P</italic> &lt; .05 vs EEN + lowPAC.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>EEN significantly reduced the number of GCs per villi compared with standard chow (<italic>P</italic> &lt; .005). EEN + lowPAC (<italic>P</italic> &lt; .05), EEN + midPAC (<italic>P</italic> &lt; .01), and EEN + highPAC (<italic>P</italic> &lt; .0001) significantly increased the number of GCs per villi compared with EEN alone. The number of GCs per villi in the EEN + highPAC group was significantly greater than in the EEN + lowPAC group (<italic>P</italic> &lt; .05). When adjusted for villi length (GCs/µL villi length) in EEN, there were no significant differences between EEN and standard chow in the number of GCs (<italic>P</italic> = .12). However, there were more GCs/villi length in the EEN + midPAC (<italic>P</italic> = .05) and EEN + highPAC (<italic>P</italic> &lt; .01) groups compared with EEN alone. A representative histomorphometric image is shown for standard chow, EEN, and EEN + highPAC (<xref ref-type="fig" rid="fig1-0148607112463076">Figure 1</xref>).</p>
<fig id="fig1-0148607112463076" position="float">
<label>Figure 1.</label>
<caption><p>Representative image of periodic acid-Schiff (PAS) base–stained ileum tissue from (A) chow, (B) EEN, and (C) EEN + highPAC. Goblet cells are stained (denoted by arrows). Measurements of villi length and crypt depth were made as indicated. 20× zoom. EEN, elemental enteral nutrition; PAC, proanthocyanidin.</p></caption>
<graphic xlink:href="10.1177_0148607112463076-fig1.tif"/>
</fig>
<p>Although the GC size (µm<sup>2</sup>) in the EEN group was smaller than in the standard chow group, this difference was not significant (<italic>P</italic> = .29) (<xref ref-type="table" rid="table4-0148607112463076">Table 4</xref>). The GC sizes in the EEN + lowPAC (<italic>P</italic> &lt; .05), EEN + midPAC (<italic>P</italic> &lt; .01), and EEN + highPAC (<italic>P</italic> &lt; .05) groups were significantly greater than EEN alone.</p>
</sec>
<sec id="section16-0148607112463076">
<title>Analysis of Luminal MUC2</title>
<p>The monomer and dimer observed, at molecular weight markers 250 and 500 kDa, respectively, were consistent with other reports of the highly oligomeric structure of intestinal MUC2.<sup><xref ref-type="bibr" rid="bibr35-0148607112463076">35</xref><xref ref-type="bibr" rid="bibr36-0148607112463076"/><xref ref-type="bibr" rid="bibr37-0148607112463076"/>-<xref ref-type="bibr" rid="bibr38-0148607112463076">38</xref></sup> The relative luminal MUC2 (<xref ref-type="fig" rid="fig2-0148607112463076">Figure 2</xref>) in the EEN and EEN + lowPAC groups was lower than in the standard chow group, although these differences failed to reach significance (<italic>P</italic> = .057). However, the relative luminal MUC2 in the EEN + highPAC (<italic>P</italic> &lt; .005) group was higher than EEN alone, but the EEN + midPAC (<italic>P</italic> = .06) group failed to reach significance. In addition, the level of MUC2 in the EEN + highPAC group was significantly greater than in the EEN + lowPAC group (<italic>P</italic> &lt; .05).</p>
<fig id="fig2-0148607112463076" position="float">
<label>Figure 2.</label>
<caption><p>Effects of feeding chow, EEN, EEN + lowPAC, EEN + midPAC, and EEN + highPAC diets on intestinal lumen MUC2 displayed in arbitrary units. EEN, elemental enteral nutrition; PAC, proanthocyanidin. *<italic>P</italic> &lt; .05 vs EEN + highPAC.</p></caption>
<graphic xlink:href="10.1177_0148607112463076-fig2.tif"/>
</fig>
</sec>
</sec>
<sec id="section17-0148607112463076" sec-type="discussion">
<title>Discussion</title>
<p>This study demonstrates that the addition of cranberry PAC to EEN solution improves ileal tissue IL-4 and IL-13 levels, GC number and size, and the secretion of intestinal MUC2, which likely contribute to the impairment of the mucosal barrier integrity previously observed by EEN alone.<sup><xref ref-type="bibr" rid="bibr2-0148607112463076">2</xref>,<xref ref-type="bibr" rid="bibr39-0148607112463076">39</xref></sup> The gastrointestinal mucosa maintains a physical and chemical barrier against 100 trillion resident bacteria as well as food and environmental antigens.<sup><xref ref-type="bibr" rid="bibr6-0148607112463076">6</xref></sup> A number of interrelated factors influence this function, including mucus glycoproteins, antimicrobial molecules, specific and nonspecific antibodies, enterocyte tight junctions, and colonization of a commensal microbiota.<sup><xref ref-type="bibr" rid="bibr40-0148607112463076">40</xref>,<xref ref-type="bibr" rid="bibr41-0148607112463076">41</xref></sup> Dietary intake of the host affects the complex interplay between these factors.<sup><xref ref-type="bibr" rid="bibr42-0148607112463076">42</xref>,<xref ref-type="bibr" rid="bibr43-0148607112463076">43</xref></sup> The route and complexity of nutrition profoundly influence the mucosal immune system, specifically the mucosal-associated lymphoid tissue.<sup><xref ref-type="bibr" rid="bibr4-0148607112463076">4</xref>,<xref ref-type="bibr" rid="bibr5-0148607112463076">5</xref>,<xref ref-type="bibr" rid="bibr44-0148607112463076">44</xref></sup> A reduction in dietary intake or complexity, such as those that occur with parenteral nutrition or administration of EEN, decreases the number of lymphocytes in Peyer’s patches and lamina propria, reduces levels of IgA-stimulating Th-2 type cytokines in the gut wall, and reduces levels of intestinal immunoglobulins (primarily IgA) compared with the feeding of a standard chow diet or administration of a complex enteral diet containing complex carbohydrates, proteins, and fats.<sup><xref ref-type="bibr" rid="bibr4-0148607112463076">4</xref>,<xref ref-type="bibr" rid="bibr34-0148607112463076">34</xref>,<xref ref-type="bibr" rid="bibr44-0148607112463076">44</xref>,<xref ref-type="bibr" rid="bibr45-0148607112463076">45</xref></sup> EEN also increases barrier permeability and significantly suppresses bacterial diversity within the gut.<sup><xref ref-type="bibr" rid="bibr2-0148607112463076">2</xref>,<xref ref-type="bibr" rid="bibr39-0148607112463076">39</xref></sup> Although the influence of dietary intake or complexity on mucosal barrier and immunity is appreciated,<sup><xref ref-type="bibr" rid="bibr41-0148607112463076">41</xref></sup> very little is known of the influence of “nonnutritive” dietary compounds such as PAC.</p>
<p>PACs are complex oligomeric polyphenolic compounds widely distributed in fruits, including grapes, cranberries, and apples, as well as other foods and beverages such as chocolate and wine.<sup><xref ref-type="bibr" rid="bibr9-0148607112463076">9</xref><xref ref-type="bibr" rid="bibr10-0148607112463076"/>-<xref ref-type="bibr" rid="bibr11-0148607112463076">11</xref></sup> Epidemiological studies suggest that PACs may have a wide range of beneficial health effects.<sup><xref ref-type="bibr" rid="bibr12-0148607112463076">12</xref><xref ref-type="bibr" rid="bibr13-0148607112463076"/>-<xref ref-type="bibr" rid="bibr14-0148607112463076">14</xref></sup> However, PACs are minimally absorbed across the enterocyte layer due to nonhydrolyzable bonds between flavan-3-ol monomeric units and their ability to complex both dietary and endogenous proteins.<sup><xref ref-type="bibr" rid="bibr15-0148607112463076">15</xref></sup> Furthermore, PAC oligomers range in DP from 3–30 or more and therefore have a higher molecular weight than other common plant polyphenols. Consequentially, &gt;95% of PACs remain in the intestinal lumen during transit through the gastrointestinal tract.<sup><xref ref-type="bibr" rid="bibr46-0148607112463076">46</xref><xref ref-type="bibr" rid="bibr47-0148607112463076"/>-<xref ref-type="bibr" rid="bibr48-0148607112463076">48</xref></sup></p>
<p>Since PACs are poorly absorbed, a number of mechanisms have been investigated to explain their potential beneficial effects. PACs have been shown to exert antioxidant and nonspecific antimicrobial functions within the gut.<sup><xref ref-type="bibr" rid="bibr20-0148607112463076">20</xref></sup> Recent animal studies also demonstrate that the addition of dietary PAC palliates chemically induced colitis, although the mechanism of this remains unclear.<sup><xref ref-type="bibr" rid="bibr49-0148607112463076">49</xref><xref ref-type="bibr" rid="bibr50-0148607112463076"/>-<xref ref-type="bibr" rid="bibr51-0148607112463076">51</xref></sup> Another important effect of PACs is their propensity to complex salivary glycoproteins when ingested, a process that causes the astringency of many fruits and beverages.<sup><xref ref-type="bibr" rid="bibr10-0148607112463076">10</xref></sup> Astringency occurs when PACs crosslink and precipitate salivary glycoproteins, and PACs with higher DP have greater effects on crosslinking and precipitation.<sup><xref ref-type="bibr" rid="bibr52-0148607112463076">52</xref></sup> Several biological effects occur in response to astringency, including increased salivary excretion, hypertrophy of the parotid gland, and shift in salivary composition to proline-rich proteins.<sup><xref ref-type="bibr" rid="bibr16-0148607112463076">16</xref></sup> Within the intestine, in vitro studies demonstrate that intraepithelial γδ T lymphocytes, in response to PACs, activate and proliferate.<sup><xref ref-type="bibr" rid="bibr53-0148607112463076">53</xref></sup> Interestingly, the level of γδ T-cell response also increases with greater DP of PACs. These observations suggest not only that PACs may play an influential role in the context of mucosal barrier physiology and immunity but also that DP of PACs may be of importance when investigating their effects. Accordingly, we previously characterized the PACs used in this experiment.<sup><xref ref-type="bibr" rid="bibr31-0148607112463076">31</xref></sup> This analysis allows for the characterization and reliable reproduction of chromatographic fractions for inclusion in experimental treatments.</p>
<p>In this study, we investigated the effects of the addition of cranberry PAC to an EEN solution on ileal tissue cytokine levels, morphology (including GC number and size), and the secretion of the primary glycoprotein MUC2 and explored the effect of physiological doses of PACs on these parameters. We used a chemically defined EEN solution administered via a gastrostomy tube as a model of an elemental enteral diet that we have previously used. The EEN administration results in reproducible effects on intestinal (and respiratory) mucosal immunity, allowing examination of changes induced with PAC.</p>
<p>Compared to chow, EEN produces significantly fewer total GCs per villi. However, when normalizing the GC numbers over villi length (GC number/µm), there were no differences between EEN and the standard chow diet. There were also no significant differences in GC size and villi length between standard chow and EEN, although EEN reduced the average measurement of both parameters. Interestingly, the number of GCs per villi length was significantly preserved in the EEN + midPAC and EEN + highPAC groups compared with EEN alone. GCs normally undergo hypertrophy and hyperplasia in response to IL-4 and IL-13, which act through the IL-4 receptor α and IL-13 receptor α1, respectively.<sup><xref ref-type="bibr" rid="bibr23-0148607112463076">23</xref>,<xref ref-type="bibr" rid="bibr54-0148607112463076">54</xref>,<xref ref-type="bibr" rid="bibr55-0148607112463076">55</xref></sup> Our data show that EEN lowered ileal IL-4 and IL-13 levels compared with standard chow. The addition of PAC to the EEN diet maintained IL-4 and IL-13 but did not significantly affect the cytokines IL-1β, TNF-α, or IL-6 (<xref ref-type="table" rid="table3-0148607112463076">Table 3</xref>). Since GCs differentiate, migrate up the villi, and slough off every 3–5 days, these findings suggest that the addition of PACs to the EEN diet alters the rate of cellular differentiation of progenitor crypt stem cells to GCs likely via changes in Th-2–type cytokines observed.<sup><xref ref-type="bibr" rid="bibr4-0148607112463076">4</xref></sup> The data also suggest PACs induce the observed effect through Th2-mediated immunity consistent with a previous study showing a similar IL-4 effect in colonic tissue following ingestion of proanthocyanidins.<sup><xref ref-type="bibr" rid="bibr50-0148607112463076">50</xref></sup> In addition, although the effects on the Th1 cytokine TNF-α were not significant across treatment groups, the trend of reduced tissue TNF-α level with increasing doses of PAC was consistent with previous work.<sup><xref ref-type="bibr" rid="bibr56-0148607112463076">56</xref></sup></p>
<p>Simultaneously, EEN suppressed the concentration of MUC2 within the lumen, although this change did not reach significance. Functionally, MUC2 forms the viscous mucin layer, which overlays the intestinal surface, allowing smooth passage of digesta. From an immunological standpoint, secreted antimicrobial proteins and peptides from Paneth cells as well as secretory IgA (sIgA) localize and are concentrated in this layer.<sup><xref ref-type="bibr" rid="bibr57-0148607112463076">57</xref></sup> These mucin glycoproteins also provide endogenous flora with a consistent nutrient source. The observed decrease in luminal MUC2 may increase susceptibility to bacterial opportunistic pathogens or intestinal inflammation, since others have shown that MUC2<sup>–/–</sup> mice are at increased risk for spontaneous colitis.<sup><xref ref-type="bibr" rid="bibr21-0148607112463076">21</xref></sup> The addition of PACs at the EEN + midPAC and EEN + highPAC doses maintained MUC2 to levels observed in the standard chow group.</p>
<p>Cranberry PAC administration at physiologic doses<sup><xref ref-type="bibr" rid="bibr26-0148607112463076">26</xref>,<xref ref-type="bibr" rid="bibr27-0148607112463076">27</xref></sup> counteracts many of the changes associated with EEN administration. One limitation of the current study is that we do not address the source of the Th2 cytokines, although studies investigating changes to tissue lymphocytes and whether a mechanism similar to astringency is responsible for these observation effects are planned. Overall, this study supports the hypothesis that reduced enteral stimulation results in the impairment of mucosal integrity and gut barrier function through the reduction in the mucin component. The current work demonstrates that the administration of EEN produces lower levels of the Th2-stimulating cytokine IL-13, lower GC number and size, and lower luminal MUC2 levels in the ileum. The addition of cranberry PAC to this diet, at physiologic doses, attenuates these changes and likely normalizes mucosal integrity. This suggests that a nonnutrition dietary component such as PAC may influence health without being absorbed from the gastrointestinal tract.</p>
</sec>
</body>
<back>
<ack>
<p>Rodrigo P. Feliciano is recipient of a BD fellowship (SFRH/BD/73067/2010) from Fundação para a Ciência e a Tecnologia, Portugal. We would like to thank Jennifer J. Meudt and Michael P. Shea for their technical assistance and Dr Martha Vestling for her assistance with mass spectrometry.</p>
</ack>
<fn-group>
<fn fn-type="other">
<p>The contents of this article do not represent the views of the Department of Veterans Affairs or the United States government.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>Financial disclosure: The project described was supported by award number I01BX001672 from the Biomedical Laboratory Research &amp; Development Service of the VA Office of Research and Development. The research was also supported by a National Institutes of Health (NIH) grant (R01 GM53439) and by the Reed Research Group.</p>
</fn>
<fn fn-type="other">
<p>This article originally appeared online on October 11, 2012.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0148607112463076">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Isaacs</surname><given-names>KL</given-names></name>
<name><surname>Lewis</surname><given-names>JD</given-names></name>
<name><surname>Sandborn</surname><given-names>WJ</given-names></name>
<name><surname>Sands</surname><given-names>BE</given-names></name>
<name><surname>Targan</surname><given-names>SR</given-names></name>
</person-group>. <article-title>State of the art: IBD therapy and clinical trials in IBD</article-title>. <source>Inflamm Bowel Dis</source>. <year>2005</year>;<volume>11</volume>(<supplement>suppl 1</supplement>):<fpage>S3</fpage>-<lpage>S12</lpage>.</citation>
</ref>
<ref id="bibr2-0148607112463076">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mosenthal</surname><given-names>AC</given-names></name>
<name><surname>Xu</surname><given-names>D</given-names></name>
<name><surname>Deitch</surname><given-names>EA</given-names></name>
</person-group>. <article-title>Elemental and intravenous total parenteral nutrition diet-induced gut barrier failure is intestinal site specific and can be prevented by feeding nonfermentable fiber</article-title>. <source>Crit Care Med</source>. <year>2002</year>;<volume>30</volume>(<issue>2</issue>):<fpage>396</fpage>-<lpage>402</lpage>.</citation>
</ref>
<ref id="bibr3-0148607112463076">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kudsk</surname><given-names>K</given-names></name>
<name><surname>Gomez</surname><given-names>F</given-names></name>
<name><surname>Kang</surname><given-names>W</given-names></name>
<name><surname>Ueno</surname><given-names>C</given-names></name>
</person-group>. <article-title>Enteral feeding of a chemically defined diet preserves pulmonary immunity but not intestinal immunity: the role of lymphotoxin beta receptor</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2007</year>;(<issue>6</issue>):<fpage>477</fpage>-<lpage>481</lpage>.</citation>
</ref>
<ref id="bibr4-0148607112463076">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>Y</given-names></name>
<name><surname>Kudsk</surname><given-names>KA</given-names></name>
<name><surname>DeWitt</surname><given-names>RC</given-names></name>
<name><surname>Tolley</surname><given-names>EA</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
</person-group>. <article-title>Route and type of nutrition influence IgA-mediating intestinal cytokines</article-title>. <source>Ann Surg</source>. <year>1999</year>;<volume>229</volume>(<issue>5</issue>):<fpage>662</fpage>-<lpage>668</lpage>.</citation>
</ref>
<ref id="bibr5-0148607112463076">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hermsen</surname><given-names>J</given-names></name>
<name><surname>Gomez</surname><given-names>F</given-names></name>
<name><surname>Sano</surname><given-names>Y</given-names></name>
<name><surname>Kang</surname><given-names>W</given-names></name>
<name><surname>Maeshima</surname><given-names>Y</given-names></name>
<name><surname>Kudsk</surname><given-names>K</given-names></name>
</person-group>. <article-title>Parenteral feeding depletes pulmonary lymphocyte populations</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2009</year>;<volume>33</volume>(<issue>5</issue>):<fpage>535</fpage>-<lpage>540</lpage>.</citation>
</ref>
<ref id="bibr6-0148607112463076">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guamer</surname><given-names>F</given-names></name>
</person-group>. <article-title>Role of intestinal flora in health and disease</article-title>. <source>Nutr Hosp</source>. <year>2007</year>;<volume>22</volume>(<supplement>suppl 2</supplement>):<fpage>14</fpage>-<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr7-0148607112463076">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Johansson</surname><given-names>ME</given-names></name>
<name><surname>Ambort</surname><given-names>D</given-names></name>
<name><surname>Pelaseyed</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Composition and functional role of the mucus layers in the intestine</article-title>. <source>Cell Mol Life Sci</source>. <year>2011</year>;<volume>68</volume>(<issue>22</issue>):<fpage>3635</fpage>-<lpage>3641</lpage>.</citation>
</ref>
<ref id="bibr8-0148607112463076">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scalbert</surname><given-names>A</given-names></name>
<name><surname>Déprez</surname><given-names>S</given-names></name>
<name><surname>Mila</surname><given-names>I</given-names></name>
<name><surname>Albrecht</surname><given-names>AM</given-names></name>
<name><surname>Huneau</surname><given-names>JF</given-names></name>
<name><surname>Rabot</surname><given-names>S</given-names></name>
</person-group>. <article-title>Proanthocyanidins and human health: systemic effects and local effects in the gut</article-title>. <source>Biofactors</source>. <year>2000</year>;<volume>13</volume>(<issue>1-4</issue>):<fpage>115</fpage>-<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr9-0148607112463076">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hellstrom</surname><given-names>JK</given-names></name>
<name><surname>Torronen</surname><given-names>AR</given-names></name>
<name><surname>Mattila</surname><given-names>PH</given-names></name>
</person-group>. <article-title>Proanthocyanidins in common food products of plant origin</article-title>. <source>J Agric Food Chem</source>. <year>2009</year>;<volume>57</volume>(<issue>17</issue>): <fpage>7899</fpage>-<lpage>7906</lpage>.</citation>
</ref>
<ref id="bibr10-0148607112463076">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Manach</surname><given-names>C</given-names></name>
<name><surname>Scalbert</surname><given-names>A</given-names></name>
<name><surname>Morand</surname><given-names>C</given-names></name>
<name><surname>Remesy</surname><given-names>C</given-names></name>
<name><surname>Jimenez</surname><given-names>L</given-names></name>
</person-group>. <article-title>Polyphenols: food sources and bioavailability</article-title>. <source>Am J Clin Nutr</source>. <year>2004</year>;<volume>79</volume>(<issue>5</issue>):<fpage>727</fpage>-<lpage>747</lpage>.</citation>
</ref>
<ref id="bibr11-0148607112463076">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reed</surname><given-names>JD</given-names></name>
<name><surname>Krueger</surname><given-names>CG</given-names></name>
<name><surname>Vestling</surname><given-names>MM</given-names></name>
</person-group>. <article-title>MALDI-TOF mass spectrometry of oligomeric food polyphenols</article-title>. <source>Phytochemistry</source>. <year>2005</year>;<volume>66</volume>(<issue>18</issue>):<fpage>2248</fpage>-<lpage>2263</lpage>.</citation>
</ref>
<ref id="bibr12-0148607112463076">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arts</surname><given-names>IC</given-names></name>
<name><surname>Hollman</surname><given-names>PC</given-names></name>
</person-group>. <article-title>Polyphenols and disease risk in epidemiologic studies</article-title>. <source>Am J Clin Nutr</source>. <year>2005</year>;<volume>81</volume>(<issue>1</issue>)(<supplement>suppl</supplement>):<fpage>317S</fpage>-<lpage>325S</lpage>.</citation>
</ref>
<ref id="bibr13-0148607112463076">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Manach</surname><given-names>C</given-names></name>
<name><surname>Mazur</surname><given-names>A</given-names></name>
<name><surname>Scalbert</surname><given-names>A</given-names></name>
</person-group>. <article-title>Polyphenols and prevention of cardiovascular diseases</article-title>. <source>Curr Opin Lipidol</source>. <year>2005</year>;<volume>16</volume>(<issue>1</issue>):<fpage>77</fpage>-<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr14-0148607112463076">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scalbert</surname><given-names>A</given-names></name>
<name><surname>Manach</surname><given-names>C</given-names></name>
<name><surname>Morand</surname><given-names>C</given-names></name>
<name><surname>Remesy</surname><given-names>C</given-names></name>
<name><surname>Jimenez</surname><given-names>L</given-names></name>
</person-group>. <article-title>Dietary polyphenols and the prevention of diseases</article-title>. <source>Crit Rev Food Sci Nutr</source>. <year>2005</year>;<volume>45</volume>(<issue>4</issue>):<fpage>287</fpage>-<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr15-0148607112463076">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hagerman</surname><given-names>AE</given-names></name>
<name><surname>Butler</surname><given-names>LG</given-names></name>
</person-group>. <article-title>The specificity of proanthocyanidin-protein interactions</article-title>. <source>J Biol Chem</source>. <year>1981</year>;<volume>256</volume>(<issue>9</issue>):<fpage>4494</fpage>-<lpage>4497</lpage>.</citation>
</ref>
<ref id="bibr16-0148607112463076">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mehansho</surname><given-names>H</given-names></name>
<name><surname>Ann</surname><given-names>DK</given-names></name>
<name><surname>Butler</surname><given-names>LG</given-names></name>
<name><surname>Rogler</surname><given-names>J</given-names></name>
<name><surname>Carlson</surname><given-names>DM</given-names></name>
</person-group>. <article-title>Induction of proline-rich proteins in hamster salivary glands by isoproterenol treatment and an unusual growth inhibition by tannins</article-title>. <source>J Biol Chem</source>. <year>1987</year>;<volume>262</volume>(<issue>25</issue>):<fpage>12344</fpage>-<lpage>12350</lpage>.</citation>
</ref>
<ref id="bibr17-0148607112463076">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>17. Mehansho</surname><given-names>H</given-names></name>
<name><surname>Carlson</surname><given-names>DM</given-names></name>
</person-group>. <article-title>Induction of protein and glycoprotein synthesis in rat submandibular glands by isoproterenol</article-title>. <source>J Biol Chem</source>. <year>1983</year>; <volume>258</volume>(<issue>10</issue>):<fpage>6616</fpage>-<lpage>6620</lpage>.</citation>
</ref>
<ref id="bibr18-0148607112463076">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gonthier</surname><given-names>MP</given-names></name>
<name><surname>Donovan</surname><given-names>JL</given-names></name>
<name><surname>Texier</surname><given-names>O</given-names></name>
<name><surname>Felgines</surname><given-names>C</given-names></name>
<name><surname>Remesy</surname><given-names>C</given-names></name>
<name><surname>Scalbert</surname><given-names>A</given-names></name>
</person-group>. <article-title>Metabolism of dietary procyanidins in rats</article-title>. <source>Free Radic Biol Med</source>. <year>2003</year>;<volume>35</volume>(<issue>8</issue>):<fpage>837</fpage>-<lpage>844</lpage>.</citation>
</ref>
<ref id="bibr19-0148607112463076">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reed</surname><given-names>JD</given-names></name>
</person-group>. <article-title>Nutritional toxicology of tannins and related polyphenols in forage legumes</article-title>. <source>J Anim Sci</source>. <year>1995</year>;<volume>73</volume>(<issue>5</issue>):<fpage>1516</fpage>-<lpage>1528</lpage>.</citation>
</ref>
<ref id="bibr20-0148607112463076">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cos</surname><given-names>P</given-names></name>
<name><surname>De Bruyne</surname><given-names>T</given-names></name>
<name><surname>Hermans</surname><given-names>N</given-names></name>
<name><surname>Apers</surname><given-names>S</given-names></name>
<name><surname>Berghe</surname><given-names>DV</given-names></name>
<name><surname>Vlietinck</surname><given-names>AJ</given-names></name>
</person-group>. <article-title>Proanthocyanidins in health care: current and new trends</article-title>. <source>Curr Med Chem</source>. <year>2004</year>;<volume>11</volume>(<issue>10</issue>):<fpage>1345</fpage>-<lpage>1359</lpage>.</citation>
</ref>
<ref id="bibr21-0148607112463076">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bergstrom</surname><given-names>KS</given-names></name>
<name><surname>Kissoon-Singh</surname><given-names>V</given-names></name>
<name><surname>Gibson</surname><given-names>DL</given-names></name>
<etal/>
</person-group>. <article-title>Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa</article-title>. <source>PLoS Pathog</source>. <year>2010</year>;<volume>6</volume>(<issue>5</issue>):<fpage>e1000902</fpage>.</citation>
</ref>
<ref id="bibr22-0148607112463076">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yusuf</surname><given-names>S</given-names></name>
<name><surname>Nok</surname><given-names>AJ</given-names></name>
<name><surname>Ameh</surname><given-names>DA</given-names></name>
<name><surname>Adelaiye</surname><given-names>AB</given-names></name>
<name><surname>Balogun</surname><given-names>EO</given-names></name>
</person-group>. <article-title>Quantitative changes in gastric mucosal glycoproteins: effect of cholinergic agonist and vagal nerve stimulation in the rat</article-title>. <source>Neurogastroenterol Motil</source>. <year>2004</year>;<volume>16</volume>(<issue>5</issue>):<fpage>613</fpage>-<lpage>619</lpage>.</citation>
</ref>
<ref id="bibr23-0148607112463076">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Finkelman</surname><given-names>FD</given-names></name>
<name><surname>Shea-Donohue</surname><given-names>T</given-names></name>
<name><surname>Goldhill</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models</article-title>. <source>Annu Rev Immunol</source>. <year>1997</year>;<volume>15</volume>:<fpage>505</fpage>-<lpage>533</lpage>.</citation>
</ref>
<ref id="bibr24-0148607112463076">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fallon</surname><given-names>PG</given-names></name>
<name><surname>Jolin</surname><given-names>HE</given-names></name>
<name><surname>Smith</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13</article-title>. <source>Immunity</source>. <year>2002</year>;<volume>17</volume>(<issue>1</issue>):<fpage>7</fpage>-<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr25-0148607112463076">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McKenzie</surname><given-names>GJ</given-names></name>
<name><surname>Bancroft</surname><given-names>A</given-names></name>
<name><surname>Grencis</surname><given-names>RK</given-names></name>
<name><surname>McKenzie</surname><given-names>AN</given-names></name>
</person-group>. <article-title>A distinct role for interleukin-13 in Th2-cell-mediated immune responses</article-title>. <source>Curr Biol</source>. <year>1998</year>;<volume>8</volume>(<issue>6</issue>):<fpage>339</fpage>-<lpage>342</lpage>.</citation>
</ref>
<ref id="bibr26-0148607112463076">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knaze</surname><given-names>V</given-names></name>
<name><surname>Zamora-Ros</surname><given-names>R</given-names></name>
<name><surname>Luján-Barroso</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study</article-title>. <source>Br J Nutr</source>. <volume>2011</volume>:<fpage>1</fpage>-<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr27-0148607112463076">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Chung</surname><given-names>SJ</given-names></name>
<name><surname>Song</surname><given-names>WO</given-names></name>
<name><surname>Chun</surname><given-names>OK</given-names></name>
</person-group>. <article-title>Estimation of daily proanthocyanidin intake and major food sources in the U.S. diet</article-title>. <source>J Nutr</source>. <year>2011</year>;<volume>141</volume>(<issue>3</issue>):<fpage>447</fpage>-<lpage>452</lpage>.</citation>
</ref>
<ref id="bibr28-0148607112463076">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kume</surname><given-names>H</given-names></name>
<name><surname>Okazaki</surname><given-names>K</given-names></name>
<name><surname>Yamaji</surname><given-names>T</given-names></name>
<name><surname>Sasaki</surname><given-names>H</given-names></name>
</person-group>. <article-title>A newly designed enteral formula containing whey peptides and fermented milk product protects mice against concanavalin A–induced hepatitis by suppressing overproduction of inflammatory cytokines</article-title>. <source>Clin Nutr</source>. <year>2012</year>;<volume>31</volume>(<issue>2</issue>):<fpage>283</fpage>-<lpage>289</lpage>.</citation>
</ref>
<ref id="bibr29-0148607112463076">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bastarache</surname><given-names>JA</given-names></name>
<name><surname>Ware</surname><given-names>LB</given-names></name>
<name><surname>Girard</surname><given-names>TD</given-names></name>
<name><surname>Wheeler</surname><given-names>AP</given-names></name>
<name><surname>Rice</surname><given-names>TW</given-names></name>
</person-group>. <article-title>Markers of inflammation and coagulation may be modulated by enteral feeding strategy</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2012</year>;<volume>36</volume>:<fpage>732</fpage>-<lpage>740</lpage>.</citation>
</ref>
<ref id="bibr30-0148607112463076">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aydogan</surname><given-names>A</given-names></name>
<name><surname>Kismet</surname><given-names>K</given-names></name>
<name><surname>Kilicoglu</surname><given-names>B</given-names></name>
<etal/>
</person-group>. <article-title>Effects of various enteral nutrition solutions on bacterial translocation and intestinal morphology during the postoperative period</article-title>. <source>Adv Ther</source>. <year>2007</year>;<volume>24</volume>(<issue>1</issue>):<fpage>41</fpage>-<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr31-0148607112463076">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feliciano</surname><given-names>RP</given-names></name>
<name><surname>Shea</surname><given-names>MP</given-names></name>
<name><surname>Shanmuganayagam</surname><given-names>D</given-names></name>
<name><surname>Krueger</surname><given-names>CG</given-names></name>
<name><surname>Howell</surname><given-names>AB</given-names></name>
<name><surname>Reed</surname><given-names>JD</given-names></name>
</person-group>. <article-title>Comparison of isolated cranberry (<italic>Vaccinium macrocarpon</italic> Ait.) proanthocyanidins to catechin and procyanidins A2 and B2 for use as standards in the 4-(dimethylamino)cinnamaldehyde assay</article-title>. <source>J Agric Food Chem</source>. <year>2012</year>;<volume>60</volume>(<issue>18</issue>):<fpage>4578</fpage>-<lpage>4585</lpage>.</citation>
</ref>
<ref id="bibr32-0148607112463076">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sitren</surname><given-names>HS</given-names></name>
<name><surname>Heller</surname><given-names>PA</given-names></name>
<name><surname>Bailey</surname><given-names>LB</given-names></name>
<name><surname>Cerda</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Total parenteral nutrition in the mouse: development of a technique</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>1983</year>;<volume>7</volume>(<issue>6</issue>):<fpage>582</fpage>-<lpage>586</lpage>.</citation>
</ref>
<ref id="bibr33-0148607112463076">
<label>33.</label>
<citation citation-type="book">
<collab>Subcommittee on Laboratory Animal Nutrition, Committee on Animal Nutrition, Board on Agriculture, National Research Council</collab>. <source>Nutrient Requirements of Laboratory Animals</source>. <edition>4th rev ed</edition>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academies Press</publisher-name>; <year>1995</year>.</citation>
</ref>
<ref id="bibr34-0148607112463076">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sano</surname><given-names>Y</given-names></name>
<name><surname>Gomez</surname><given-names>F</given-names></name>
<name><surname>Hermsen</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Parenteral nutrition induces organ specific alterations in polymeric immunoglobulin receptor levels</article-title>. <source>J Surg Res</source>. <year>2008</year>;<volume>149</volume>(<issue>2</issue>):<fpage>236</fpage>-<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr35-0148607112463076">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aksoy</surname><given-names>N</given-names></name>
<name><surname>Thornton</surname><given-names>DJ</given-names></name>
<name><surname>Corfield</surname><given-names>A</given-names></name>
<name><surname>Paraskeva</surname><given-names>C</given-names></name>
<name><surname>Sheehan</surname><given-names>JK</given-names></name>
</person-group>. <article-title>A study of the intracellular and secreted forms of the MUC2 mucin from the PC/AA intestinal cell line</article-title>. <source>Glycobiology</source>. <year>1999</year>;<volume>9</volume>(<issue>7</issue>):<fpage>739</fpage>-<lpage>746</lpage>.</citation>
</ref>
<ref id="bibr36-0148607112463076">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Asker</surname><given-names>N</given-names></name>
<name><surname>Axelsson</surname><given-names>MA</given-names></name>
<name><surname>Olofsson</surname><given-names>SO</given-names></name>
<name><surname>Hansson</surname><given-names>GC</given-names></name>
</person-group>. <article-title>Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and dimers to the Golgi apparatus</article-title>. <source>J Biol Chem</source>. <year>1998</year>;<volume>273</volume>(<issue>30</issue>):<fpage>18857</fpage>-<lpage>18863</lpage>.</citation>
</ref>
<ref id="bibr37-0148607112463076">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Axelsson</surname><given-names>MA</given-names></name>
<name><surname>Asker</surname><given-names>N</given-names></name>
<name><surname>Hansson</surname><given-names>GC</given-names></name>
</person-group>. <article-title>O-glycosylated MUC2 monomer and dimer from LS 174T cells are water-soluble, whereas larger MUC2 species formed early during biosynthesis are insoluble and contain nonreducible intermolecular bonds</article-title>. <source>J Biol Chem</source>. <year>1998</year>;<volume>273</volume>(<issue>30</issue>):<fpage>18864</fpage>-<lpage>18870</lpage>.</citation>
</ref>
<ref id="bibr38-0148607112463076">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Larsson</surname><given-names>JM</given-names></name>
<name><surname>Karlsson</surname><given-names>H</given-names></name>
<name><surname>Crespo</surname><given-names>JG</given-names></name>
<etal/>
</person-group>. <article-title>Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation</article-title>. <source>Inflamm Bowel Dis</source>. <year>2011</year>;<volume>17</volume>(<issue>11</issue>):<fpage>2299</fpage>-<lpage>2307</lpage>.</citation>
</ref>
<ref id="bibr39-0148607112463076">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kajiura</surname><given-names>T</given-names></name>
<name><surname>Takeda</surname><given-names>T</given-names></name>
<name><surname>Sakata</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis</article-title>. <source>Dig Dis Sci</source>. <year>2009</year>;<volume>54</volume>(<issue>9</issue>):<fpage>1892</fpage>-<lpage>1900</lpage>.</citation>
</ref>
<ref id="bibr40-0148607112463076">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ouellette</surname><given-names>AJ</given-names></name>
<name><surname>Selsted</surname><given-names>ME</given-names></name>
</person-group>. <article-title>Paneth cell defensins: endogenous peptide components of intestinal host defense</article-title>. <source>FASEB J</source>. <year>1996</year>;<volume>10</volume>(<issue>11</issue>):<fpage>1280</fpage>-<lpage>1289</lpage>.</citation>
</ref>
<ref id="bibr41-0148607112463076">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fukatsu</surname><given-names>K</given-names></name>
<name><surname>Kudsk</surname><given-names>KA</given-names></name>
</person-group>. <article-title>Nutrition and gut immunity</article-title>. <source>Surg Clin North Am</source>. <year>2011</year>;<volume>91</volume>(<issue>4</issue>):<fpage>755</fpage>-<lpage>770</lpage>, vii.</citation>
</ref>
<ref id="bibr42-0148607112463076">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hermsen</surname><given-names>J</given-names></name>
<name><surname>Sano</surname><given-names>Y</given-names></name>
<name><surname>Kudsk</surname><given-names>K</given-names></name>
</person-group>. <article-title>Food fight! Parenteral nutrition, enteral stimulation and gut-derived mucosal immunity</article-title>. <source>Langenbecks Arch Surg</source>. <year>2009</year>;<volume>394</volume>(<issue>1</issue>):<fpage>17</fpage>-<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr43-0148607112463076">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pierre</surname><given-names>JF</given-names></name>
<name><surname>Heneghan</surname><given-names>AF</given-names></name>
<name><surname>Tsao</surname><given-names>FH</given-names></name>
<etal/>
</person-group>. <article-title>Route and type of nutrition and surgical stress influence secretory phospholipase A2 secretion of the murine small intestine</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2011</year>;<volume>35</volume>(<issue>6</issue>):<fpage>748</fpage>-<lpage>756</lpage>.</citation>
</ref>
<ref id="bibr44-0148607112463076">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Kudsk</surname><given-names>KA</given-names></name>
<name><surname>Gocinski</surname><given-names>B</given-names></name>
<name><surname>Dent</surname><given-names>D</given-names></name>
<name><surname>Glezer</surname><given-names>J</given-names></name>
<name><surname>Langkamp-Henken</surname><given-names>B</given-names></name>
</person-group>. <article-title>Effects of parenteral and enteral nutrition on gut-associated lymphoid tissue</article-title>. <source>J Trauma</source>. <year>1995</year>;<volume>39</volume>(<issue>1</issue>):<fpage>44</fpage>-<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr45-0148607112463076">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>King</surname><given-names>B</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Kudsk</surname><given-names>K</given-names></name>
</person-group>. <article-title>A temporal study of TPN-induced changes in gut-associated lymphoid tissue and mucosal immunity</article-title>. <source>Arch Surg</source>. <year>1997</year>;<volume>132</volume>(<issue>12</issue>):<fpage>1303</fpage>-<lpage>1309</lpage>.</citation>
</ref>
<ref id="bibr46-0148607112463076">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Deprez</surname><given-names>S</given-names></name>
<name><surname>Mila</surname><given-names>I</given-names></name>
<name><surname>Huneau</surname><given-names>JF</given-names></name>
<name><surname>Tome</surname><given-names>D</given-names></name>
<name><surname>Scalbert</surname><given-names>A</given-names></name>
</person-group>. <article-title>Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial Caco-2 cells</article-title>. <source>Antioxid Redox Signal</source>. <year>2001</year>;<volume>3</volume>(<issue>6</issue>):<fpage>957</fpage>-<lpage>967</lpage>.</citation>
</ref>
<ref id="bibr47-0148607112463076">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baba</surname><given-names>S</given-names></name>
<name><surname>Osakabe</surname><given-names>N</given-names></name>
<name><surname>Natsume</surname><given-names>M</given-names></name>
<name><surname>Terao</surname><given-names>J</given-names></name>
</person-group>. <article-title>Absorption and urinary excretion of procyanidin B2 [epicatechin-(4beta-8)-epicatechin] in rats</article-title>. <source>Free Radic Biol Med</source>. <year>2002</year>;<volume>33</volume>(<issue>1</issue>):<fpage>142</fpage>-<lpage>148</lpage>.</citation>
</ref>
<ref id="bibr48-0148607112463076">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Donovan</surname><given-names>JL</given-names></name>
<name><surname>Manach</surname><given-names>C</given-names></name>
<name><surname>Rios</surname><given-names>L</given-names></name>
<name><surname>Morand</surname><given-names>C</given-names></name>
<name><surname>Scalbert</surname><given-names>A</given-names></name>
<name><surname>Remesy</surname><given-names>C</given-names></name>
</person-group>. <article-title>Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B3</article-title>. <source>Br J Nutr</source>. <year>2002</year>;<volume>87</volume>(<issue>4</issue>):<fpage>299</fpage>-<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr49-0148607112463076">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>YH</given-names></name>
<name><surname>Yang</surname><given-names>XL</given-names></name>
<name><surname>Wang</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Effects of proanthocyanidins from grape seed on treatment of recurrent ulcerative colitis in rats</article-title>. <source>Can J Physiol Pharmacol</source>. <year>2010</year>;<volume>88</volume>(<issue>9</issue>):<fpage>888</fpage>-<lpage>898</lpage>.</citation>
</ref>
<ref id="bibr50-0148607112463076">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>XL</given-names></name>
<name><surname>Cai</surname><given-names>YQ</given-names></name>
<name><surname>Qin</surname><given-names>H</given-names></name>
<name><surname>Wu</surname><given-names>YJ</given-names></name>
</person-group>. <article-title>Therapeutic effect and mechanism of proanthocyanidins from grape seeds in rats with TNBS-induced ulcerative colitis</article-title>. <source>Can J Physiol Pharmacol</source>. <year>2008</year>;<volume>86</volume>(<issue>12</issue>):<fpage>841</fpage>-<lpage>849</lpage>.</citation>
</ref>
<ref id="bibr51-0148607112463076">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshioka</surname><given-names>Y</given-names></name>
<name><surname>Akiyama</surname><given-names>H</given-names></name>
<name><surname>Nakano</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Orally administered apple procyanidins protect against experimental inflammatory bowel disease in mice</article-title>. <source>Int Immunopharmacol</source>. <year>2008</year>;<volume>8</volume>(<issue>13-14</issue>):<fpage>1802</fpage>-<lpage>1807</lpage>.</citation>
</ref>
<ref id="bibr52-0148607112463076">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vidal</surname><given-names>S</given-names></name>
<name><surname>Francis</surname><given-names>L</given-names></name>
<name><surname>Guyot</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>The mouth-feel properties of grape and apple proanthocyanidins in a wine-like medium</article-title>. <source>J Sci Food Agriculture</source>. <year>2003</year>;<volume>83</volume>(<issue>6</issue>):<fpage>564</fpage>-<lpage>573</lpage>.</citation>
</ref>
<ref id="bibr53-0148607112463076">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holderness</surname><given-names>J</given-names></name>
<name><surname>Hedges</surname><given-names>JF</given-names></name>
<name><surname>Daughenbaugh</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Response of gammadelta T Cells to plant-derived tannins</article-title>. <source>Crit Rev Immunol</source>. <year>2008</year>;<volume>28</volume>(<issue>5</issue>):<fpage>377</fpage>-<lpage>402</lpage>.</citation>
</ref>
<ref id="bibr54-0148607112463076">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Steenwinckel</surname><given-names>V</given-names></name>
<name><surname>Louahed</surname><given-names>J</given-names></name>
<name><surname>Lemaire</surname><given-names>MM</given-names></name>
<etal/>
</person-group>. <article-title>IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa</article-title>. <source>J Immunol</source>. <year>2009</year>;<volume>182</volume>(<issue>8</issue>): <fpage>4737</fpage>-<lpage>4743</lpage>.</citation>
</ref>
<ref id="bibr55-0148607112463076">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Iwashita</surname><given-names>J</given-names></name>
<name><surname>Sato</surname><given-names>Y</given-names></name>
<name><surname>Sugaya</surname><given-names>H</given-names></name>
<name><surname>Takahashi</surname><given-names>N</given-names></name>
<name><surname>Sasaki</surname><given-names>H</given-names></name>
<name><surname>Abe</surname><given-names>T</given-names></name>
</person-group>. <article-title>mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells</article-title>. <source>Immunol Cell Biol</source>. <year>2003</year>;<volume>81</volume>(<issue>4</issue>):<fpage>275</fpage>-<lpage>282</lpage>.</citation>
</ref>
<ref id="bibr56-0148607112463076">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>YH</given-names></name>
<name><surname>Ge</surname><given-names>B</given-names></name>
<name><surname>Yang</surname><given-names>XL</given-names></name>
<etal/>
</person-group>. <article-title>Proanthocyanidins from grape seeds modulates the nuclear factor–kappa B signal transduction pathways in rats with TNBS-induced recurrent ulcerative colitis</article-title>. <source>Int Immunopharmacol</source>. <year>2011</year>;<volume>11</volume>(<issue>10</issue>):<fpage>1620</fpage>-<lpage>1627</lpage>.</citation>
</ref>
<ref id="bibr57-0148607112463076">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meyer-Hoffert</surname><given-names>U</given-names></name>
<name><surname>Hornef</surname><given-names>MW</given-names></name>
<name><surname>Henriques-Normark</surname><given-names>B</given-names></name>
<etal/>
</person-group>. <article-title>Secreted enteric antimicrobial activity localises to the mucus surface layer</article-title>. <source>Gut</source>. <year>2008</year>;<volume>57</volume>(<issue>6</issue>):<fpage>764</fpage>-<lpage>771</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>